Genetic Study in Young Onset Parkinson's Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by China Medical University Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Hui-Chun Huang, China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01529970
First received: February 7, 2012
Last updated: February 8, 2012
Last verified: February 2012
  Purpose

Parkinson's disease (PD) is the second most frequent neurodegenerative disorder after Alzheimer's disease. It causes motor dysfunctions, such as bradykinesia, resting tremor, rigidity and postural instability. Although PD appears to be sporadic in most cases, several causative genes and susceptibility factors have been identified that cause familial forms of the disease with Mendelian inheritance with autosomal dominant or autosomal recessive inheritance.

Approximately 5~10% of patients with the clinical picture of PD carry a mutation in one of the known genes that cause monogenic forms of the disorder. The average age at onset is between 60 and 80 years and the average age of diagnosis is 60 years. Onset of primary parkinsonism before 50 years is known as early onset parkinsonism(EOP). Onset between 20 and 50 years is known as young-onset PD. Onset at younger than 20 years is known as juvenile parkinsonism (JP). At least, 13 loci and 9 genes are reported. The investigators study is aimed to screen the clinical diagnosed familial EOP for the common mutation site by PCR/DNA sequencing. The gene for screen are Parkin (pattern: PARK2), PINK1 (pattern: PARK6) and ATP13A2 (pattern: PARK9).


Condition
Parkinson Disease

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by China Medical University Hospital:

Estimated Enrollment: 60
Study Start Date: January 2012
Groups/Cohorts
parkinson's disease, young onset
Normal

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

patients from China Medical University Hospital

Criteria

Inclusion Criteria:

  • Idiopathic Parkinson's disease (according to UK Parkinson's Disease Society Brain Bank clinical diagnosis criteria)
  • Onset before 50-year-old or positive family history

Exclusion Criteria:

  • Secondary parkinsonism
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01529970

Locations
Taiwan
China Medical University Hospital
Taichung, Taiwan
Sponsors and Collaborators
China Medical University Hospital
  More Information

No publications provided

Responsible Party: Hui-Chun Huang, Attending Physician, China Medical University Hospital
ClinicalTrials.gov Identifier: NCT01529970     History of Changes
Other Study ID Numbers: DMR100-IRB-252
Study First Received: February 7, 2012
Last Updated: February 8, 2012
Health Authority: Taiwan: Institutional Review Board

Additional relevant MeSH terms:
Parkinson Disease
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders

ClinicalTrials.gov processed this record on October 28, 2014